Document is current
Any future updates will be listed below
-
Authors
Chandrasekaran, Sita S.
Agrawal, Shreeya
Fanton, Alison
Jangid, Aditya R.
Charrez, Bérénice
Escajeda, Arturo M.
Son, Sungmin
Mcintosh, Roger
Tran, Huyen
Bhuiya, Abdul
de León Derby, María Díaz
Switz, Neil A.
Armstrong, Maxim
Harris, Andrew R.
Prywes, Noam
Lukarska, Maria
Biering, Scott B.
Smock, Dylan C. J.
Mok, Amanda
Knott, Gavin J.
Dang, Qi
Van Dis, Erik
Dugan, Eli
Kim, Shin
Liu, Tina Y.
,
Hamilton, Jennifer R.
Lin-Shiao, Enrique
Stahl, Elizabeth C.
Tsuchida, Connor A.
Giannikopoulos, Petros
McElroy, Matthew
McDevitt, Shana
Zur, Arielle
Sylvain, Iman
Ciling, Alison
Zhu, Madeleine
Williams, Clara
Baldwin, Alisha
Moehle, Erica A.
Kogut, Katherine
Eskenazi, Brenda
Harris, Eva
Stanley, Sarah A.
Lareau, Liana F.
Tan, Ming X.
Fletcher, Daniel A.
Doudna, Jennifer A.
Savage, David F.
Hsu, Patrick D. http://orcid.org/0000-0002-9380-2648
-
Funding
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (N66001-20-2-4033, N66001-20-2-4033)
NSF-GRFP
Howard Hughes Medical Institute
- License Information
-
More Information
Article History
Received: 1 December 2020
Accepted: 30 June 2022
First Online: 11 August 2022
Competing interests
: The Regents of the University of California and Wainamics have filed patents related to this work. P.D.H. is a co-founder of Spotlight Therapeutics and Moment Biosciences and serves on the board of directors and scientific advisory board, and is a scientific advisory board member to Vial Health and Serotiny. D.F.S. is a co-founder of Scribe Therapeutics and a scientific advisory board member of Scribe Therapeutics and Mammoth Biosciences. J.A.D. is a co-founder of Caribou Biosciences, Editas Medicine, Scribe Therapeutics and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Caribou Biosciences, Intellia Therapeutics, eFFECTOR Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Synthego, Algen Biotechnologies, Felix Biosciences and Inari. J.A.D. is a Director at Johnson & Johnson and has research projects sponsored by Biogen, Pfizer, AppleTree Partners and Roche. The other authors declare no competing interests.
Free to read: This content has been made available to all.
